Rapportage 12 Audit Commissie Doping : periode september t/m december 2005 / M.I. van Dijk, S.J.U. Veen-van der Wielen, C. van Bentum. - Arnhem : Audit Commissie Doping, 2006.
- Rapportage t.b.v. de Algemene vergadering NOC*NSF 23 mei 2006.
- Halfjaarlijkse rapportage aan de Algemene Vergadering van NOC*NSF, de staatssecretaris van Volksgezondheid, Welzijn en Sport en het bestuur van de Dopingautoriteit.

Inhoud:

- Hoofdstuk 1 Inleiding
- Hoofdstuk 2 Gegevens verzameling
- Hoofdstuk 3 Toelichting overzichten
- Hoofdstuk 4 Bevindingen
- Hoofdstuk 5 Conclusies en aanbevelingen
- Bijlage Rapportage Audit Commissie Doping 23 mei 2006

Canadian Centre for Ethics in Sport annual report 2005-2006 / Canadian Centre for Ethics in Sport

CONTENTS

• Highlights
• Committed to Values
• Governance
• Anti-Doping Leadership
• Community Sport Leadership
• International Leadership
• Auditors’ Report

George Hartman (“The Respondent”) is a member of the United States Judo Association (“USA Judo”). In 2005, Respondent was ranked number two in the United States under the 100kg weight category. Respondent has been in the USADA’s Out-of-Competition testing pool since November of 2004.

Respondent tested positive for testosterone in a March 2,2005 Out-of-Competition drug test. He admits being administered testosterone, but argues that his testosterone treatment was medically necessary as a result of his disability. Respondent requested that his two-year period of ineligibility be reduced under the Exceptional Circumstances provision of the World Anti Doping Code ("Code") Article 10.5. In addition, Respondent requested protection under the Americans with Disability Act ("ADA").
The Panel finds that Respondent failed to sustain his burden of proof that he suffers from a disability. As a consequence, the Panel imposes a two-year period of ineligibility, along with other sanctions as required by the Code.

AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2005-06 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1833-8976

Table of Contents iv
Figures vi
Acronyms vii
About this report ix
Overview 1
Chair’s message 2
Organisational overview 4
ASDA Snapshot 2005–06 4
Outcome and output structure 5
ASADA Snapshot: 2005–06 6
2005–06 ASADA highlights 9
2006–07 ASADA outlook 9
ASDA’s Organisational Structure 10
ASADA’s Organisational Structure 11
Australia’s Anti-Doping Framework 12
Performance review 13
Performance reports 14
Resources for Outcome 14
Outcome 1 14
Output 1.1 Drug testing program 15
Detection 15
Enforcement 22
Compliance 22
Deterrence 23
Key Projects 23
Output 1.2 Education, communication and advocacy services 26
Education and communication 27
Advocacy 33
Management Accountability 41
Corporate Governance 42
Senior management committees 43
Risk management 46
External scrutiny 49
Management of Human Resources 51
Financials 57
Discretionary grants 58
Asset management 58
Purchasing 59
Consultants 59
Competitive tendering and contracting 60
Compliance requirements 61
Australian Sports Drug Agency 63
Corporate Governance 64
Financial management 66
Contracting and purchasing 67
People 68
Australian Sports Drug Medical Advisory Committee 73
Financial Statements 77
Appendices 157
Appendix A: Doping Control statistics 1989 to 30 June 2006 158
Appendix B: Register of Notifiable Events (RNE) 2005–06 159
Appendix C: List of International Incidences (LII) 2005–06 162
Appendix D: Register of Findings (RoF) 2005–06 163
Appendix E: International anti-doping arrangements and Doping Control agreements 164
Appendix F: The functions, powers and delegations of ASADA in accordance with
the ASADA Act 2006 166
Appendix G: Powers of the Minister under the ASADA Act 168
Appendix H: The objects, functions and powers of ASDA as specified in the ASDA Act 169
Appendix I: Powers of the Minister under the ASDA Act 171
Appendix J: ASADA Staffing Statistics as at 30 June 2006 172
Appendix K: ASDA Staffing Statistics as at 13 March 2006 174
Appendix L: Freedom of Information 176
Appendix M: 2001-05 ASDA Strategy Plan 177
Appendix N: ASDMAC Functions (excerpt from ASADA Regulations) 178
Appendix O: ASDMAC Approvals by Sport July 1 2005 to 30 June 2006 179
Glossary 183
Compliance Index 185
Index 188
Figures
Figure 1: ASDA’s outcome and output structure 5
Figure 2: Changes to the outcome and output structure 2006–07 8
Figure 3: ASADA’s outcome and output structure 2006–07 8
Figure 4: ASDA’S organisational structure 10
Figure 5: ASADA’S organisational structure 11
Figure 6: Australia’s anti-doping framework 12
Figure 7: Resources for outcome 14
Figure 8: Output 1.1 performance measures 15
Figure 9: ASADA’s Doping Control statistics for 2005–06 17
Figure 10: Register of Notifiable Events and Register of Findings trends 1998 to 2006 21
Figure 11: Output 1.2 performance measures 26
Figure 12: Distribution of education and communication products and services 30
Figure 13: ASADA Member details as at 30 June 2006 44
Figure 14: Expenditure on new and existing contracts 60
Figure 15: Service provider contracts over $100,000 60
Figure 16: Media advertising agencies 61
Figure 17: ASDA Board details as at 13 March 2006 64
Figure 18: ASDA Audit Commitee details as at 13 March 2006 66
Figure 19: ASDMAC budget 2005–06 76

Results of the WADA monitoring program regarding substances which are not on the 2005 Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport. These substances are:
- Caffeine
- Pseudoephedrine
- Phenylpropanolamine
- Synephrine
- Phenylephrine
- Pipradrol
- Bupropion
- Morphine / Codeine

International Literature Review: Attitudes, Behaviours, Knowledge and Education – Drugs in Sport: Past, Present and Future / Susan Backhouse, Jim McKenna, Simon Robinson, Andrew Atkin. – Carnegie Research Institute; Leeds Metropolitan University. – Leeds : Leeds Metropolitan University. – 2007. – Review prepared for the World Anti-Doping Agency (WADA)

Based upon the need identified by WADA, the review provides an extensive annotated bibliography of peer reviewed publications in the social sciences regarding
(a) predictors and precipitating factors in doping;
(b) attitudes and behaviours towards doping and
(c) anti-doping education or prevention programs.

The database created during this review should be maintained so that future research in this area can be centrally documented and recorded.

WADA - Play True Magazine
2007, issue 1
Beyond the athlete - The fight against doping arms itself against large-scale doping schemes and trafficking with new strategies
and partnerships.
----------------------------------------------------------------------------------
Content

Editorials
01 R.W. Pound: Beyond the Athlete
02 Interpol: Committed to the Fight

Cover story
03 The Way Forward
09 Highlights from a Study on Trafficking
10 The Australian Model
12 Trafficking: What the Code and Convention Say
12 UNESCO Conference Update
13 A Parent's Perspective

Code Review & Consultation
15 Consultation Update
15 IAAF Conference
16 WADA Athlete Committee Input

Features
17 Open Letter to Those Who Promote Medical Supervision of Doping
18 WADA President in Beijing
19 Athlete Profile: Rosa Mota
21 Partner Profile: FIBA
23 WADA Outreach
23 WADA’s “Level the Playing Field” DVD
24 WADA Coach’s Tool Kit

WADA Updates & Calendar
25 RADOs
25 ADAMS
25 Staff Announcements
25 2007 Prohibited List
26 New Lab Accreditation
26 Athlete’s Passport
27 WADA Event Calendar

Attitudes, Behaviours, Knowledge and Education – Drugs in Sport: Past, Present and Future / Susan Backhouse, Jim McKenna, Simon Robinson, Andrew Atkin

Based upon the need identified by WADA, the review provides an extensive annotated bibliography of peer reviewed publications in the social sciences regarding (a) predictors and precipitating factors in doping; (b) attitudes and behaviours towards doping and (c) anti-doping education or prevention programs. The database created during this review should be maintained so that future research in this area can be centrally documented and recorded.

The Findings
One hundred and three articles met the inclusion criteria and were considered in this review. Of these, 69 articles considered the attitudes of various target groups, 18 studies sought to examine the precipitating factors and correlates of performance enhancing drug use and 16 articles presented the findings of education intervention studies or model development in relation to doping in sport.

Conclusion
The evidence presented in this review leads to a simple conclusion: the weak evidence base undermines strategic planning and limits the capacity to target appropriate and efficacious education programmes to abate doping in sport.

Recommendations
This review has highlighted a number of key priorities in the social science research field. For example, adopting a Behavioural Epidemiological Framework would direct research efforts. Employing a variety of research designs from the upper echelons of the evidence hierarchy would facilitate the examination of causality and developing psychometrically sound measurement tools would enhance the validity and reliability of findings. Finally, the collaborative networks between practitioner and researcher need to be established so that evidence based findings inform the strategic planning of interventions and enable effective monitoring and evaluation.